Lesson
Thyroid Axis, Hormone Biology, and Testing
Thyroid interpretation begins with feedback physiology, the difference between total and free hormone, and recognition of settings in which TSH is not a reliable stand-alone signal.
- TRH and TSH feedback
- T4 to T3 conversion
- Free versus total hormone
- Primary versus central disease
- Assay context
Pituitary TSH stimulates synthesis, release, and thyroid growth
The gland releases mostly T4 and tissues generate much of T3
Free hormone suppresses TRH and TSH unless central disease disrupts the axis
Trace synthesis and feedback
TSH stimulates iodide handling, organification, coupling, hormone release, and thyroid growth. The gland releases mostly T4, while peripheral deiodinases generate much of circulating T3. Free hormone feeds back at the pituitary and hypothalamus.
Interpret patterns rather than isolated values
High TSH with low free T4 supports primary hypothyroidism. Low TSH with high free T4 or T3 supports thyrotoxicosis. Low or inappropriately normal TSH with low free T4 raises concern for central hypothyroidism and requires pituitary assessment.
Recognize distorted measurements
Pregnancy changes binding proteins and reference needs. Severe nonthyroidal illness can alter TSH and hormone patterns. Biotin and other assay interferences, recent iodine, amiodarone, glucocorticoids, dopamine, and timing of thyroid medicine can complicate interpretation.
Quick check
Lesson
Hypothyroidism: Cause, Classification, and Diagnosis
Hypothyroidism ranges from autoimmune gland failure to central disease, transient thyroiditis, treatment effects, and medication-related dysfunction, with treatment urgency determined by biochemical and clinical severity.
- Hashimoto thyroiditis
- Overt hypothyroidism
- Subclinical hypothyroidism
- Central disease
- Reversible causes
The thyroid gland cannot meet demand
Repeat, contextualize, and assess progression risk
Evaluate pituitary function and adrenal safety
Classify the biochemical state
Overt primary hypothyroidism combines high TSH with low free T4. Subclinical primary hypothyroidism combines high TSH with free T4 within range. Central hypothyroidism is defined through free T4 and pituitary context rather than a high TSH requirement.
Find the cause
Hashimoto thyroiditis is common and may be supported by thyroid peroxidase antibodies. Other causes include thyroid surgery or radioiodine, neck radiation, congenital disease, iodine imbalance, thyroiditis, infiltrative disease, and medicines such as lithium or amiodarone.
Decide when observation is reasonable
A positive thyroid antibody result with normal thyroid function does not itself require levothyroxine. Mild subclinical disease is interpreted through repeat testing, symptoms, TSH magnitude, antibodies, cardiovascular context, age, fertility, and pregnancy rather than a single universal threshold.
Quick check
Lesson
Levothyroxine Selection, Dosing, and Administration
Levothyroxine is standard replacement for most hypothyroidism, but dose, formulation, timing, and titration must fit residual thyroid function, body size, age, cardiac reserve, pregnancy, and the product being used.
- Levothyroxine standard
- Full versus cautious replacement
- Consistent administration
- Absorption interactions
- Formulation continuity
Match dose to severity, size, age, cardiac reserve, and pregnancy
Control food, supplements, binders, and formulation changes
Reassess after a new steady pattern forms
Choose the starting intensity
Younger adults with clear primary hypothyroidism and no cardiac limitation may tolerate near-full replacement. Older adults, people with coronary disease, and those with long-standing severe disease usually begin more cautiously and titrate from symptoms and laboratory response.
Create consistent absorption
Tablets are commonly taken with water on an empty stomach at a consistent interval before breakfast or at bedtime well after food. Calcium, iron, aluminum-containing products, bile acid sequestrants, and selected binders can reduce absorption and require product-specific separation.
Use formulations deliberately
Tablets, soft-gel capsules, liquids, and intravenous products are not operationally identical. Gastric disorders, feeding tubes, adherence barriers, excipient sensitivity, and interacting therapy can make a different formulation useful, but any switch should trigger planned reassessment.
Quick check
Lesson
Monitoring Replacement and Solving an Unstable TSH
An unstable TSH is a diagnostic problem that can reflect timing, adherence, administration, product changes, interactions, malabsorption, weight or physiologic change, assay interference, or the wrong diagnosis.
- Steady-state reassessment
- Adherence reconstruction
- Interaction review
- Malabsorption
- Overreplacement
Timing, missed doses, catch-up behavior, storage, and product
Food, calcium, iron, medicines, weight, pregnancy, and gut function
Use symptoms, TSH or free T4 context, rhythm, and bone risk
Time reassessment to pharmacology
After a routine dose or formulation change, TSH is commonly reassessed after enough time for a new steady pattern, often about six weeks. Once stable, the interval can lengthen, while pregnancy, symptoms, major illness, and interacting changes justify closer review.
Troubleshoot before chasing the number
Ask about missed doses, catch-up behavior, food timing, calcium or iron, acid-suppressing therapy, binders, enteral feeds, product switching, storage, gastrointestinal disease, and whether the dose was taken shortly before laboratory collection.
Prevent overreplacement
Excess thyroid hormone can contribute to palpitations, tremor, insomnia, atrial arrhythmia, angina, and bone loss. The goal is biochemical and clinical euthyroidism, not suppression of TSH unless a separate specialist-managed indication exists.
Quick check
Lesson
Severe Hypothyroidism and Myxedema Coma
Myxedema coma is decompensated severe hypothyroidism with impaired thermoregulation, ventilation, circulation, metabolism, and cognition that requires critical care and treatment before every result is available.
- Clinical recognition
- Airway and temperature
- IV thyroid hormone
- Adrenal coverage
- Precipitant control
Ventilation, careful warming, glucose, sodium, and perfusion
Obtain samples when feasible and give stress-dose glucocorticoid
Individualize loading and maintenance to severity and cardiac risk
Recognize decompensation
Altered mental status, hypothermia, bradycardia, hypotension, hypoventilation, hyponatremia, hypoglycemia, and a precipitating infection or medication can form the syndrome. The name does not require literal coma or visible myxedema.
Stabilize before fine adjustment
Protect ventilation and circulation, use careful rewarming, correct glucose and electrolytes cautiously, obtain cortisol and thyroid studies when feasible, and give stress-dose glucocorticoid coverage until adrenal insufficiency is reasonably excluded.
Replace hormone under critical-care guidance
Intravenous levothyroxine is central, with loading and maintenance individualized for age, weight, cardiac risk, and severity. Some protocols add liothyronine selectively, but potential benefit must be weighed against arrhythmia and ischemia risk.
Quick check
Lesson
Thyrotoxicosis: Cause and Diagnostic Differentiation
Thyrotoxicosis describes excessive thyroid hormone action, while hyperthyroidism specifically means increased synthesis by the thyroid gland, and the distinction determines whether synthesis-blocking drugs can work.
- Graves disease
- Toxic nodules
- Thyroiditis
- Exogenous hormone
- Iodine and amiodarone
High gland activity can respond to thionamide therapy
Stored hormone leaks from damaged follicles
Exposure history redirects testing and treatment
Separate production from release
Graves disease, toxic multinodular goiter, and toxic adenoma increase synthesis. Destructive thyroiditis releases stored hormone and often has low uptake. Exogenous hormone and some iodine-related states require a different causal analysis.
Use targeted discriminators
TSH receptor antibodies can support Graves disease. Uptake and scan patterns can distinguish diffuse stimulation, focal autonomy, and low-uptake states when not contraindicated. Ultrasound answers structural questions but does not replace every functional test.
Read the full clinical signal
Goiter, orbitopathy, nodules, neck pain, postpartum timing, medication exposure, recent iodinated contrast, weight change, tremor, pulse, and T3-predominant disease guide efficient testing. Pregnancy and lactation constrain radionuclide testing.
Quick check
Lesson
Methimazole and Propylthiouracil
Thionamides reduce new hormone synthesis, but selection and monitoring are shaped by pregnancy, thyroid storm, liver risk, rare agranulocytosis, expected delay, and the cause of thyrotoxicosis.
- Methimazole preference
- PTU exceptions
- Agranulocytosis
- Hepatic injury
- Monitoring and counseling
Routine first choice for most nonpregnant patients
Early pregnancy, storm, or defined methimazole intolerance
Fever, severe sore throat, jaundice, or dark urine need prompt evaluation
Match the drug to the setting
Methimazole is generally preferred because it is effective with a more convenient schedule and avoids the severe hepatic risk that limits PTU. PTU remains important during or just before the first trimester when an antithyroid drug is needed, in thyroid storm, and when methimazole cannot be used and definitive therapy is unsuitable.
Counsel for rare urgent toxicity
Fever or severe sore throat can signal agranulocytosis and requires prompt medical evaluation and a blood count before further dosing is cleared. Jaundice, dark urine, severe fatigue, abdominal symptoms, or pruritus can signal liver injury and require urgent evaluation.
Monitor response without overreacting to TSH
Free T4 and T3 guide early adjustment because TSH can remain suppressed after hormone levels improve. Baseline blood count and liver assessment help interpret later symptoms, while routine serial testing is individualized rather than a substitute for symptom-triggered evaluation.
Quick check
Lesson
Symptom Control and Adjunctive Therapy
Adjunctive therapy controls adrenergic symptoms, hormone release, enterohepatic recycling, inflammation, or peripheral conversion while cause-directed treatment takes effect.
- Beta blockade
- Iodide sequence
- Glucocorticoids
- Cholestyramine
- Comorbidity limits
Reduce adrenergic symptoms with hemodynamic awareness
Stop synthesis before inhibiting release
Reduce conversion or increase elimination in selected severe states
Control adrenergic symptoms
Beta blockers can reduce tremor, palpitations, and tachycardia before the cause is fully established. Propranolol at sufficient exposure can also reduce peripheral T4 to T3 conversion, but agent and intensity should reflect hemodynamics and pulmonary or conduction risk.
Use iodine in the correct sequence
Pharmacologic iodide can acutely inhibit hormone release and is used in selected surgical preparation and emergency protocols. In synthesis-driven thyrotoxicosis, give a thionamide before iodine so the iodine load does not provide substrate for new hormone synthesis.
Reserve additional tools for defined needs
Glucocorticoids reduce peripheral conversion and support adrenal physiology in thyroid storm. Cholestyramine can increase hormone elimination in selected severe cases. These are adjuncts, not substitutes for diagnosis and definitive cause-directed care.
Quick check
Lesson
Radioactive Iodine, Surgery, and Long-Term Strategy
Long-term Graves disease and autonomous thyroid disease can be managed with continued antithyroid therapy, radioactive iodine, or surgery, with no single option preferred for every patient.
- Shared selection
- Radioactive iodine
- Thyroidectomy
- Eye disease
- Long-term follow-up
Preserve the gland with adherence, toxicity, and relapse tradeoffs
Avoid in pregnancy and consider eye disease and delayed effect
Favor rapid control or structural indications with operative planning
Choose rather than default
Antithyroid therapy preserves the gland but can relapse and requires adherence and monitoring. Radioactive iodine gradually destroys active tissue. Surgery offers rapid definitive control but carries anesthesia, recurrent laryngeal nerve, bleeding, and hypoparathyroidism risks.
Recognize major constraints
Radioactive iodine is contraindicated in pregnancy and lactation and can worsen thyroid eye disease in susceptible Graves disease. Large compressive goiter, concerning nodules, coexisting hyperparathyroidism, or a need for rapid control can favor surgery.
Plan the state after treatment
Radioactive iodine and total thyroidectomy commonly lead to hypothyroidism requiring lifelong levothyroxine. Follow-up must detect residual or recurrent hyperthyroidism, post-treatment hypothyroidism, calcium problems after surgery, and eye disease progression.
Quick check
Lesson
Thyroid Storm
Thyroid storm is decompensated thyrotoxicosis with systemic organ dysfunction, not simply a very high hormone concentration, and treatment must begin from the clinical syndrome.
- Clinical diagnosis
- Critical-care stabilization
- Thionamide then iodine
- Beta blockade and steroids
- Trigger control
Airway, circulation, temperature, glucose, volume, and trigger
Thionamide comes before iodine
Use steroids and hemodynamically appropriate beta blockade
Diagnose the decompensated state
High fever, marked tachycardia or atrial arrhythmia, heart failure, gastrointestinal or hepatic dysfunction, agitation, delirium, seizure, or coma in a thyrotoxic patient support the diagnosis. Scoring systems organize evidence but do not replace judgment.
Sequence multimodal therapy
Stabilize airway, circulation, temperature, glucose, and volume; give a thionamide; then give iodine after an appropriate interval. Add glucocorticoid therapy and symptom control. PTU is often selected initially because it also reduces peripheral T4 to T3 conversion.
Match beta blockade to circulation
Propranolol is useful when circulation is stable, but severe heart failure or shock can make aggressive beta blockade dangerous. Short-acting titratable therapy and invasive monitoring may be needed. Treat infection, medication interruption, surgery, childbirth, ischemia, or another trigger in parallel.
Quick check
Lesson
Preconception, Pregnancy, Lactation, and Postpartum
Pregnancy changes thyroid physiology, reference interpretation, hormone requirements, fetal exposure, medication choice, monitoring cadence, and the meaning of Graves antibodies.
- Pregnancy-specific testing
- Levothyroxine adjustment
- PTU and methimazole
- TRAb and fetal risk
- Postpartum thyroid disease
Adjust levothyroxine early and monitor in pregnancy context
Balance methimazole embryopathy and PTU liver risk
TRAb can affect the fetus and postpartum causes can diverge
Protect maternal T4 availability
Patients already using levothyroxine commonly need an early dose increase when pregnancy is confirmed, followed by prompt and frequent thyroid testing. The exact adjustment and target use current pregnancy-specific guidance, prior treatment, thyroid reserve, and laboratory context.
Minimize fetal and maternal drug risk
When an antithyroid drug is required in early pregnancy, PTU is generally preferred during or just before the first trimester because methimazole has a characteristic embryopathy risk. Later therapy is reassessed because PTU can cause severe liver injury. Use the lowest effective antithyroid dose and do not use radioactive iodine.
Look beyond maternal hormone levels
TSH receptor antibodies can cross the placenta after current or prior Graves disease, including after definitive maternal therapy. Antibody level and maternal treatment can trigger fetal surveillance. Postpartum thyroiditis and Graves relapse require diagnostic separation, while lactation decisions use drug, dose, timing, and current guidance.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 100 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.